Research and Markets: Italy In Vitro Diagnostics Market Outlook to 2018 – Clinical Chemistry Genetic Testing …

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/6d4r6v/italy_in_vitro) has announced the addition of GlobalData's new report "Italy In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture" to their offering.

This new report provides key market data on the Italy In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Histology And Cytology, Microbiology Culture and Genetic Testing. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics market categories - Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Histology And Cytology, Microbiology Culture and Genetic Testing.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the market categories.

- Global corporate-level profiles of key companies operating within the Italy In Vitro Diagnostics market.

Reasons to buy

View original post here:
Research and Markets: Italy In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing ...

ATS Labs Acquires Microcheck, Inc., Expands Microbiology Services to Include Microbial Identification

EAGAN, Minn.--(BUSINESS WIRE)--

ATS Labs, Inc. announces the acquisition of Microcheck, Inc., a provider of contract microbial identification testing in strict accordance with Current Good Manufacturing Practices (cGMPs).

The acquisition of Microcheck strengthens ATS Labs microbiology services to sterile and non-sterile manufacturing operations. This positions our company as the premier comprehensive provider of microbiology services for industries that actively manage microbial environmental contamination, says Brian C. Brosdahl, Ph.D., ATS Labs president and chief executive officer.

As a leader in microbial identification of bacteria, fungi and yeasts, Microcheck supports environmental monitoring and quality control programs for the pharmaceutical, medical device, cosmetics, personal care, agriculture/food, raw materials, water testing, research, bioremediation and other related industries. The companys expert scientific team uses state-of-the-art technologies for bacterial identification, fungal identification, gene sequencing, environmental monitoring and microbiology testing. Since 1988, Microchecks team has identified more than 500,000 isolates to species level.

Now, ATS Labs can offer environmental monitoring support, followed by microbial identification of environmental isolates, and then complete the service by providing disinfection qualification testing, adds Brosdahl.

A leading global provider of antimicrobial and biocide testing services, ATS Labs is committed to improving public health and generating value for customers that range from international Fortune 500 companies to small privately held firms. For more than 20 years, ATS Labs has been an expert partner to the developers, manufacturers and users of antimicrobial products. In addition to its customers high satisfaction, the company maintains a positive reputation with all the regulatory agencies and a flawless record of U.S. Environmental Protection Agency facility and data audits.

To learn more about ATS Labs comprehensive range of microbiology, virology and product chemistry services, please visit http://www.ats-labs.com.

Here is the original post:
ATS Labs Acquires Microcheck, Inc., Expands Microbiology Services to Include Microbial Identification

Canada In Vitro Diagnostics Market Analysis and Forecasts to 2017 in New Research Report at RnRMarketResearch.com

RnRMarketResearch.com adds Latest Report on Canada In Vitro Diagnostics Market Outlook to 2017 Clinical Chemistry Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture to its store.

Dallas, Texas (PRWEB) January 13, 2013

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis of industry experts.

Scope

Market size and company share data for In Vitro Diagnostics market categories Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.

Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.

2010 company shares and distribution shares data for each of the seven market categories and global corporate-level profiles of key companies operating within the Canada In Vitro Diagnostics market.

Key players covered include Siemens Healthcare, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and others.

Get your copy of this report @ http://www.rnrmarketresearch.com/canada-in-vitro-diagnostics-market-outlook-2017-clinical-chemistry-genetic-testing-haematology-histology-and-cytology-immuno-chemistry-infectious-immunology-microbiology-culture-market-report.html

Reasons to buy

See the original post here:
Canada In Vitro Diagnostics Market Analysis and Forecasts to 2017 in New Research Report at RnRMarketResearch.com

Unraveling the Secrets of Viruses – Video


Unraveling the Secrets of Viruses
Science for the Public, May 17, 2011. John Connor, PhD, Assistant Professor of Microbiology, Boston University School of Medicine. Viruses may be minimal structures, but many types, such as HIV and Ebola, can be lethal. Although genetically much simpler than the organisms they infect, the ability of viruses to mutate rapidly makes it extremely hard to block them. The Connor Lab at Boston University School of Medicine studies the mechanisms that make viruses so successful. Professor Connor explains what viruses are, how they pirate living cells to replicate themselves, and why they are able to mutate so quickly. Dr. Connor and his colleagues are applying the understanding of viral replication mechanisms to research that will lead to the development of new antiviral drugs and vaccines.

By: scienceforpublic

Go here to read the rest:
Unraveling the Secrets of Viruses - Video

OPENING LAUNCHING GENOM(Created with After Effects CS5) – Video


OPENING LAUNCHING GENOM(Created with After Effects CS5)
Video Launching Study Group GENOM(Generation of Microbiology and Moleculer) in UIN Syarif Hidayatullah Jakarta at 5 January 2012. Beginner Creator with Adobe After Effects CS5. You can follow me: FP FB:www.facebook.com or twitter: @dna_uin or web blog: http://www.dnauin.wordpress.com

By: Rois Muxid

Continued here:
OPENING LAUNCHING GENOM(Created with After Effects CS5) - Video

COMING SOON GENOM(created with After Effects CS5) – Video


COMING SOON GENOM(created with After Effects CS5)
Video Launching Study Group GENOM(Generation of Microbiology and Moleculer) in UIN Syarif Hidayatullah Jakarta at 5 January 2012. Beginner Creator with Adobe After Effects CS5. You can follow me: FP FB:www.facebook.com or twitter: @dna_uin or web blog: http://www.dnauin.wordpress.com

By: Rois Muxid

See the original post here:
COMING SOON GENOM(created with After Effects CS5) - Video

Research and Markets: United Kingdom In Vitro Diagnostics Market Outlook to 2018 – Clinical Chemistry Genetic Testing …

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/zjsndj/united_kingdom_in) has announced the addition of GlobalData's new report "United Kingdom In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture" to their offering.

The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Histology And Cytology, Microbiology Culture and Genetic Testing.

The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Scope

- Market size and company share data for In Vitro Diagnostics market categories

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the market categories.

- Global corporate-level profiles of key companies operating within the market.

Reasons to Buy

The rest is here:
Research and Markets: United Kingdom In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing ...

Café Scientifique Topic 27: Scientific Construction of Race – Video


Café Scientifique Topic 27: Scientific Construction of Race
How much do you really know about the geographic, racial and ethnic origins of your personal ancestors? How old were you when you first learned about race? Come join us in a fascinating conversation about the evolution of race and what scientists say about race with Mike Lange, Associate Professor of Anthropology, Champlain College and John Burke, Professor, Microbiology Molecular Genetics, UVM. View the exhibit Race: Are We So Different? during social time.

By: echovermont

Link:
Café Scientifique Topic 27: Scientific Construction of Race - Video

Research and Markets: Middle East and Africa In Vitro Diagnostics Market Outlook to 2018 – Clinical Chemistry, Genetic …

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/pcxchs/middle_east_and) has announced the addition of GlobalData's new report "Middle East and Africa In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture" to their offering.

Our new report, Middle East and Africa In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture provides key market data on the Middle East and Africa In Vitro Diagnostics Market - South Africa, Israel and Saudi Arabia.

The report provides value (USD million) data for all the market categories - Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

Scope

- Countries covered include South Africa, Israel and Saudi Arabia.. - Market size and company share data for In Vitro Diagnostics market categories - Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing. - Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018. - 2011 company shares and distribution shares data for each of the market categories and countries. - Global corporate-level profiles of key companies operating within the Middle East and Africa In Vitro Diagnostics market.

Key Topics Covered:

1 List of Tables and Figures

2 Introduction

3 In Vitro Diagnostics in Middle East and Africa

Read the original here:
Research and Markets: Middle East and Africa In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic ...

Recent advances in Microbiology – Rapid Mycoplasma Test

SMis Pharmaceutical Microbiology conference taking place on the 30th & 31st January London will provide attendees with an expert and highly accredited speaker line who will focus on the latest developments and procedures used in the identification and prevention of contaminating agents, updates on new rules and regulations and the challenges facing the Pharmaceutical Microbiology industry.

London (PRWEB UK) 9 January 2013

SMi is pleased to confirm John Duguid, Principle Analytical Scientist, Genzyme as a speaker at the upcoming event. Mr. Duguid is currently responsible for developing, validating, and transferring molecular biology assays for rapid microbiology and cell differentiation application s, managing complex projects to implement process changes, and using statistical process control tools to implement process analytical technology for cell therapy products

He will address the selection, validation and automation of rapid mycoplasma test, looking at how to do a selection using a risk based approach, validation according to PhEur 2.6.7 and automation for routine testing. Attending will enable delegates to hear

Over 13 speakers from top pharma companies that include Sanofi-Aventis, Genzyme, GlaxoSmithKline, Pfizer, Merck and MedImmune

For more information visit http://www.smi-online.co.uk/goto/pharma-microbiology59.asp alternatively contact Cem Tuna on +44 0 207 827 6184 or email on ctuna(at)smi-online(dot)co(dot)uk

Sonal Patel SMi Group Ltd 0207 827 6106 Email Information

Here is the original post:
Recent advances in Microbiology – Rapid Mycoplasma Test

Research and Markets: Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/tg7hqs/microbiology) has announced the addition of GlobalData's new report "Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018" to their offering.

The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within seven market categories - Bacterial Identification & Susceptibility Testing, Blood Culture, Mycobacteria Culture, Microbiology Analyzers, Immunological Culture Identification, Parasitology Culture and Mycology Culture.

The report also provides company shares and distribution shares data for the overall Microbiology Culture market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

Scope

- Market size data for Microbiology Culture market categories

- Annualized market revenues ($m), volume (units) and average price ($) data for each of the segments and sub-segments within the seven market categories. Data from 2004 to 2011, forecast forward for seven years to 2018.

- 2011 company shares and distribution shares data for the overall Microbiology Culture market in each of the aforementioned countries.

- Global corporate-level profiles of key companies operating within the Microbiology Culture market in BRICS.

Reasons to Buy

See original here:
Research and Markets: Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

Salmonella [HD] – SketchyMicro USMLE Microbiology Review – Video


Salmonella [HD] - SketchyMicro USMLE Microbiology Review
Website: http://www.SketchyMicro.com Twitter @SketchyMicro "Salmonella #39;s Salmon Dinner" Illustration: Bryan L Narration: Andrew B Created By: Andrew B, Bryan L and Saud S We encourage you to add your own material to the sketch. Print up the PDFs on our website, start sketching, then let us know how you incorporated new material in a creative way! Remember to like the video and leave a comment!

By: SketchyMicro

More:
Salmonella [HD] - SketchyMicro USMLE Microbiology Review - Video

Research and Markets: Taiwan In Vitro Diagnostics Market Outlook to 2018

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/hs3b2m/taiwan_in_vitro) has announced the addition of GlobalData's new report "Taiwan In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture" to their offering.

Our new report, Taiwan In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture provides key market data on the Taiwan In Vitro Diagnostics market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within market categories - Immuno Chemistry, Infectious Immunology, Clinical Chemistry, Haematology, Microbiology Culture, Histology And Cytology and Genetic Testing. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Scope

- Market size and company share data for In Vitro Diagnostics market categories - Immuno Chemistry, Infectious Immunology, Clinical Chemistry, Haematology, Microbiology Culture, Histology And Cytology and Genetic Testing.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the market categories.

- Global corporate-level profiles of key companies operating within the Taiwan In Vitro Diagnostics market.

- Key players covered include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Sysmex Corporation, Siemens Healthcare, Beckman Coulter, Inc., bioMerieux S.A. and others.

Key Topics Covered:

See the original post here:
Research and Markets: Taiwan In Vitro Diagnostics Market Outlook to 2018

Research and Markets: India In Vitro Diagnostics Market Outlook to 2018 – Clinical Chemistry Genetic Testing …

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/fhrbht/india_in_vitro) has announced the addition of GlobalData's new report "India In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture" to their offering.

Our new report, India In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture provides key market data on the India In Vitro Diagnostics market. The report provides value (USD million) data for each segment and sub-segment within seven market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Scope

- Market size and company share data for In Vitro Diagnostics market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.

- Annualized market revenues (USD million) data for each of the segments and sub-segments within seven market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the seven market categories.

- Global corporate-level profiles of key companies operating within the India In Vitro Diagnostics market.

- Key players covered include F. Hoffmann-La Roche Ltd., Transasia Bio-Medicals Ltd., Siemens Healthcare, Beckman Coulter, Inc., Abbott Laboratories, Span Diagnostics Ltd. and others.

Key Topics Covered:

Read more:
Research and Markets: India In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing ...